• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝伐单抗局部及结膜下应用对兔眼角膜新生血管的影响。

Effects of topical and subconjunctival use of bevacizumab on corneal neovascularization in rabbits' eyes.

作者信息

Lopes Gerson Jorge Aparecido, Casella Antonio Marcelo Barbante, Oguido Ana Paula, Matsuo Tiemi

机构信息

Department of Clinical Surgery, Universidade Estadual de Londrina, Londrina, PR, Brazil.

Department of Statistics, Universidade Estadual de Londrina, Londrina, PR, Brazil.

出版信息

Arq Bras Oftalmol. 2017 Jul-Aug;80(4):252-256. doi: 10.5935/0004-2749.20170061.

DOI:10.5935/0004-2749.20170061
PMID:28954027
Abstract

PURPOSE

: To evaluate and compare the effects of topical application and subconjunctival injection of bevacizumab on corneal neovascularization (CNV) in rabbits' eyes after chemical burning of the cornea.

METHODS

: The animals were randomly distributed into four groups of five animals. In one group, the drug was instilled, while in another, it was administered by subconjunctival injection. The two procedures using bevacizumab were compared with instillation and subconjunctival injection of saline solution (S). Neovascularization was evaluated according to the size of the invasion area of new blood vessels and through computerized analysis of this area. The data were analyzed using the Kruskal-Wallis test followed by Dunn's test for two-by-two comparison of the groups, to assess the external examination of CNV. Analysis of variance was used to assess the area of CNV. P<0.05 was considered statistically significant.

RESULTS

: Assessing both the external examination and the invasion area of neovessels on the 5th and 10th days, there was a clear difference between the groups. The group to which saline solution had been applied showed higher scores for CNV, as well as increases in the invasion area of neovessels. Two-by-two comparison of groups revealed no significant differences. However, an analysis of the factors involved (injection vs. instillation and bevacizumab vs. saline solution) showed that injection did not differ from instillation, but that bevacizumab differed from saline solution.

CONCLUSION

: Bevacizumab showed an inhibitory effect on CNV in rabbits' eyes after chemical burning of the cornea. There was no difference between the topical or subconjunctival administration of bevacizumab in the inhibition of CNV.

摘要

目的

评估并比较贝伐单抗局部应用和结膜下注射对兔角膜化学伤后角膜新生血管化(CNV)的影响。

方法

将动物随机分为四组,每组五只。一组滴注药物,另一组结膜下注射药物。将使用贝伐单抗的两种给药方式与滴注和结膜下注射生理盐水(S)进行比较。根据新生血管侵袭区域的大小并通过对该区域的计算机分析来评估新生血管化情况。数据采用Kruskal-Wallis检验,随后进行Dunn检验以对各组进行两两比较,用于评估CNV的外部检查。采用方差分析评估CNV的面积。P<0.05被认为具有统计学意义。

结果

在第5天和第10天评估外部检查和新生血管的侵袭区域时,各组之间存在明显差异。应用生理盐水的组CNV得分更高,新生血管侵袭区域也有所增加。各组两两比较未发现显著差异。然而,对相关因素(注射与滴注以及贝伐单抗与生理盐水)的分析表明,注射与滴注无差异,但贝伐单抗与生理盐水有差异。

结论

贝伐单抗对兔角膜化学伤后的CNV有抑制作用。贝伐单抗局部或结膜下给药在抑制CNV方面无差异。

相似文献

1
Effects of topical and subconjunctival use of bevacizumab on corneal neovascularization in rabbits' eyes.贝伐单抗局部及结膜下应用对兔眼角膜新生血管的影响。
Arq Bras Oftalmol. 2017 Jul-Aug;80(4):252-256. doi: 10.5935/0004-2749.20170061.
2
Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats.角膜新生血管的预防:实验性大鼠中不同剂量球结膜下注射贝伐单抗与局部用药形式的比较。
Ophthalmic Res. 2011;46(1):50-4. doi: 10.1159/000322061. Epub 2011 Jan 6.
3
Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model.贝伐单抗和舒尼替尼对兔眼模型结膜下及局部用药抑制角膜新生血管的作用
Cornea. 2013 May;32(5):689-95. doi: 10.1097/ICO.0b013e3182801645.
4
The effect of bevacizumab on corneal neovascularization in rabbits.贝伐单抗对兔角膜新生血管形成的影响。
Korean J Ophthalmol. 2010 Aug;24(4):230-6. doi: 10.3341/kjo.2010.24.4.230. Epub 2010 Aug 3.
5
Topical and subconjunctival bevacizumab for corneal neovascularization in an experimental rat model.贝伐单抗局部和结膜下给药治疗实验性大鼠角膜新生血管。
Ophthalmic Res. 2012;48(3):118-23. doi: 10.1159/000337139. Epub 2012 Apr 24.
6
Efficacy of topical aflibercept versus topical bevacizumab for the prevention of corneal neovascularization in a rat model.局部应用阿柏西普与局部应用贝伐单抗在大鼠模型中预防角膜新生血管形成的疗效比较
Exp Eye Res. 2016 May;146:224-232. doi: 10.1016/j.exer.2016.03.021. Epub 2016 Mar 26.
7
The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model.贝伐单抗对兔角膜新生血管、炎症和再上皮化的影响。
Clinics (Sao Paulo). 2011;66(8):1443-50. doi: 10.1590/s1807-59322011000800023.
8
Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).通过结膜下注射贝伐单抗(阿瓦斯汀)抑制实验性角膜新生血管形成。
Cornea. 2008 Apr;27(3):349-52. doi: 10.1097/ICO.0b013e31815cf67d.
9
Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits.他克莫司与贝伐单抗对兔角膜新生血管化的比较研究。
Cornea. 2015 Apr;34(4):449-55. doi: 10.1097/ICO.0000000000000336.
10
Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats.角膜新生血管的防治:实验大鼠中不同剂量结膜下注射贝伐单抗与皮质类固醇的比较
Ophthalmic Res. 2009;42(2):90-5. doi: 10.1159/000224783. Epub 2009 Jun 18.

引用本文的文献

1
A Systematic Review of Tear Vascular Endothelial Growth Factor and External Eye Diseases.泪液血管内皮生长因子与眼表疾病的系统评价
Int J Mol Sci. 2024 Jan 23;25(3):1369. doi: 10.3390/ijms25031369.
2
Effect of adalimumab on experimental corneal neovascularization model.阿达木单抗对实验性角膜新生血管模型的影响。
Int Ophthalmol. 2023 Jun;43(6):2119-2128. doi: 10.1007/s10792-023-02695-1. Epub 2023 Apr 4.
3
Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab.结膜下注射贝伐单抗治疗难治性角膜新生血管
Case Rep Ophthalmol. 2020 Dec 7;11(3):652-657. doi: 10.1159/000510114. eCollection 2020 Sep-Dec.
4
Prevention of Corneal Neovascularization; a Preliminary Experimental Study in Rabbits.角膜新生血管的预防;在兔身上的初步实验研究。
Med Hypothesis Discov Innov Ophthalmol. 2020;9(1):47-55. Epub 2020 Jan 1.
5
Comparison of the inhibitory effect of different doses of subconjunctival bevacizumab application in an experimental model of corneal neovascularization.不同剂量结膜下注射贝伐单抗在角膜新生血管实验模型中的抑制作用比较
Int J Ophthalmol. 2018 Jul 18;11(7):1090-1095. doi: 10.18240/ijo.2018.07.03. eCollection 2018.